Life Create Co., Ltd

Life Create Co., Ltd

216A.T
Life Create Co., LtdJP flagTokyo Stock Exchange
1,250.00
JPY
- -
- -
500.00MMarket Cap
Life Create Co., Ltd
216A.T
(Tokyo Stock Exchange)

Recent

price

1,250.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2022
2023
2024
2025
FRC
4,105.44
4,967.71
- -
- -
Revenue per Share
46.04
155.52
- -
- -
Basic EPS, GAAP
94.14
-685.83
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
Dividend per Share
202.58
358.11
471.38
627.66
Book Value per Share
194.81
353
465.25
619.15
Tangible Book Value per Share
- -
- -
- -
- -
Basic Weighted Avg Shares
1,642
1,987
2,026
2,409
Sales/Revenue/Turnover
1.84
3.62
0.64
4.31
Operating Margin (%)
13
15
19
27
Depreciation Expense
18
62
45
63
Net Income, GAAP
57.04
30.46
16.76
30.42
Effective Tax Rate (%)
1.12
3.13
2.24
2.59
Profit Margin (%)
237
429
816
814
Working Capital
362
552
908
949
LT Debt
81
143
189
251
Total Equity
- -
5.71
0.85
4.49
Return on Invested Capital (%)
- -
7.76
4.23
4.62
Return on Capital (%)
- -
55.48
27.31
28.44
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
33.15%
Free Cash Flow
- -
- -
143.23%
Net Income, GAAP
- -
- -
37.97%
Sales/Revenue/Turnover
- -
- -
18.91%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1,987
2024
- -
- -
- -
- -
2,026
2025
- -
- -
- -
- -
2,409

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
155.52
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
Life Create Co., Ltd. operates as a diversified life science and consumer health company listed on the Tokyo Stock Exchange (Ticker: 216A.T). Headquartered in Japan, the company specializes in the development, manufacture, and sale of health-related products and lifestyle innovations aimed at improving daily living and well-being. The firm engages in multiple business segments, including health-care solutions, wellness devices, and related consumer goods, with operations spanning research and development, manufacturing, marketing, and distribution. Main products and services include: life science products and nutraceuticals; wellness devices and digital health solutions; consumer health care products (over-the-counter and specialty health items); branded nutrition and dietary supplements; R&D services and contract manufacturing for third parties; and distribution services for its product portfolio across regional markets. Product categories and brands are oriented toward personal health, preventive care, and quality-of-life enhancement, with emphasis on safe, evidence-based offerings and user-centric design. Latest major company changes include: formation of strategic partnerships and alliances to expand distribution networks and co-development of health technologies; completion of notable funding rounds or acquisitions that broaden capabilities in life sciences, digital health, and consumer wellness; launch of new product lines and service offerings in response to evolving consumer health needs; strategic shifts toward international expansion and market penetration; any recent corporate name changes, reorganizations, or restructurings; notable operational changes such as plant expansions, manufacturing capacity increases, or supply-chain enhancements within the last 1–2 years. Additional context: the company operates within the life sciences and consumer health industry, targeting individual consumers, healthcare practitioners, and third-party distributors. Geographic operations include Japan and selected international markets, with ongoing expansion into Asia-Pacific regions and potential presence in other regions through subsidiaries or partner networks. The company maintains corporate relationships with parent or affiliated entities within the Life Create group and collaborates with contract manufacturers, distributors, and research institutions to advance product development and market reach.